Thorsten Feldkamp
Publications by Year
Research Areas
Acute Kidney Injury Research, Renal Transplantation Outcomes and Treatments, Renal Diseases and Glomerulopathies, Complement system in diseases, Dialysis and Renal Disease Management
Most-Cited Works
- → Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome(2013)1,539 cited
- → Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury(2013)1,348 cited
- → Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers(2014)283 cited
- → Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis(2009)119 cited
- → Measurement of urinary cystatin C by particle-enhanced nephelometric immunoassay: precision, interferences, stability and reference range(2004)101 cited
- → An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients(2019)96 cited
- → Serum cystatin C in mouse models: a reliable and precise marker for renal function and superior to serum creatinine(2008)93 cited
- → Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation(2019)68 cited
- → Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus(2010)65 cited
- → Accumulation of nonesterified fatty acids causes the sustained energetic deficit in kidney proximal tubules after hypoxia-reoxygenation(2005)65 cited